For years, drug experts have issued warnings about marijuana, but an authoritative report issued today acknowledges its potential benefits – and… Read More
Fred Hutchinson Cancer Research Center, which has spun-out companies such as Juno Therapeutics and Nohla Therapeutics in recent years, is continuing… Read More
New data from Seattle’s Juno Therapeutics shows promising results for one of its immunotherapy treatments, JCAR017. The drug was studied as a treatment… Read More
Impel NeuroPharma, a Seattle-based biotechnology and pharmaceutical company, announced a $36 million Series C round to develop neurological drugs and… Read More
Seattle-based Nohla Therapeutics, a biotech startup spun out of the Fred Hutchinson Cancer Research Center, just announced a whopping $43.5 million… Read More
Seattle-based biotech company PhaseRx develops drug candidates to treat rare, often life-threatening liver diseases, and one of their candidates just got… Read More
There are two basic models for scientific research — industry and academia — and each has its strengths. Academia can support sustained, long-term… Read More
Juno Therapeutics, the Seattle-based biotech company developing immunotherapy treatments for cancer, announced it has placed a voluntary hold on the clinical… Read More